Catalyst Pharmaceuticals appoints Mary Coleman to newly created IR role | IR Magazine

Retrieved on: 2021-08-17 16:45:08

Tags for this article:

Click the tags to see associated articles and topics

Catalyst Pharmaceuticals appoints Mary Coleman to newly created IR role | IR Magazine. View article details on hiswai:

Excerpt

Coleman joins Catalyst with more than 20 years of investor relations and corporate communications experience in the biotechnology and specialty ...

Article found on: www.irmagazine.com